Download Files:
CDK8-IN-3
SKU
HY-111463-10 mg
Category Reference compound
Tags Cancer; Metabolic Disease; Inflammation/Immunology, CDK, Cell Cycle/DNA Damage
$400 – $680
Products Details
Product Description
– CDK8-IN-3 is an inhibitor of CDK8 extracted from patent WO2016041618A1, compound example 1.7.
Web ID
– HY-111463
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture and light)
Shipping
– Room Temperature
Applications
– Metabolism-protein/nucleotide metabolism
Molecular Formula
– C22H23N5O2
References
– [1]Kai S, et al. Preparation of substituted indazoles as CDK8 inhibitors for treatment of proliferative diseases. WO 2016041618 A1 20160324
CAS Number
– 1884500-15-5
Molecular Weight
– 389.45
Compound Purity
– 99.21
SMILES
– O=C(NCCOC)C1=CC=C2C(C(CC3=CC=C(C4=CN(C)N=C4)C=C3)=NN2)=C1
Clinical Information
– No Development Reported
Research Area
– Cancer; Metabolic Disease; Inflammation/Immunology
Solubility
– DMSO : 50 mg/mL (ultrasonic)
Target
– CDK
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.